Sanrabine IV infusion 150mg is an injectable drug by Asahi Kasei Pharma, containing Enocitabine, a chemotherapeutic agent primarily used in the treatment of certain types of cancer, including acute myeloid leukemia (AML) and other hematologic malignancies. It has a YJ code of 4224402D1036 and is standardized as 150mg 1 bottle.
Sanrabine IV infusion 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →